US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,561.67

-8.0795-0.51%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,579.75

Open:1,579.75

Low:1,559.99

Close:1,569.77

Volume:33.22M

Turnover:3.25B

Market Cap:1.63T

Float Cap:1.56T

Loading ...

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

The Second Act of Biotech

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BK4599/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1561.6876,"timestamp":1789070002274,"preClose":1569.7671,"halted":0,"volume":33248980,"delay":0,"changeRate":-0.005147,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-8.079468,"latestTime":"09-10 15:53:22 EDT","open":1579.7471,"high":1579.7471,"low":1559.9921,"amount":3254460080.782888,"amplitude":0.012585,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.43172,"peRate":27.673423,"turnoverRate":0.003124,"increases":0,"decrements":7,"flats":0,"marketCap":1629134091264,"floatMarketCap":1562957833536},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1579.7471,"amplitude":0.012585,"preClose":1569.7671,"low":1559.9921,"pbRate":"9.43172","latestPrice":1561.6736,"volume":33223763,"delay":0,"open":1579.7471,"prevYearClose":1494.5856,"prevWeekClose":1629.0011,"prevMonthClose":1629.2258,"prevQuarterClose":1614.7615,"fiveDayClose":1646.5784,"twentyDayClose":1672.5226,"sixtyDayClose":1541.5948,"secType":"PLATE","market":"US","turnoverRate":0.003123,"peRate":27.673423,"marketCap":1629227412480,"floatMarketCap":1563056700224,"timestamp":1789069999687,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","OZEM","THNR","LU1093756168.USD","NVOX","BK4588","IE00BZ1G4Q59.USD","NVOC","BK4532","PPH","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","BK4599","NVO","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE00BKVL7J92.USD","LU0154236417.USD","THNR","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4585","BK4599","BK4007","NVO","NVOH","OZEM","NVOC","IE00BZ1G4Q59.USD","BK4588","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002232.USD","BK4599","SG9999002224.SGD","BK4550","WDNA","BK4139","BK4532","LU0234572021.USD","BK4581","LU1057294990.SGD","LU1066053197.SGD","MRNX","LU1883839398.USD","LU0225771236.USD","BK4007","BK4592","BK4533","LU0985481810.HKD","LU1066051498.USD","LU1894683348.USD","BK4568","IE000M9KFDE8.USD","LU2596442595.SGD","BK4501","BK4588","IE00BLSP4452.SGD","LU1023059063.AUD","MRNA","MRNY","IDNA","GNOM","LU0289739699.SGD","SG9999013999.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0321505439.SGD","LU0868494617.USD","SG9999011175.SGD","BK4585","LGHT","SG9999001176.SGD","SG9999003800.SGD","LU0170899867.USD","BK4551","LU0225284248.USD","LU0306806265.USD","IE00BBT3K403.USD","LU0122379950.USD","BK4534","BK4548","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1894683264.USD","PFE","IE00BLSP4239.USD","SG9999001176.USD","SGXZ57979304.SGD","OZEM","IE0002270589.USD","LU0306807586.USD","LU0058720904.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","LU2756315664.SGD","LU2324357040.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","IE0001KFT4U8.USD","LU1366192091.USD","LU2461242641.AUD","LU1868836591.USD","LU2168563687.JPY","LU2471134523.USD","IE0004445239.USD","SG9999017495.SGD","LU1291159041.SGD","IXJ","MHIP","IE00BK4W5M84.HKD","IE00BWXC8680.SGD","LU2456880835.USD","LU2750360641.GBP","LU0225283273.USD","IE0005OL40V9.USD","AGNG","LU1804176565.USD","IE00BFSS7M15.SGD","LLII","LU0256863811.USD","LU1280957306.USD","RXL","CANC","LU0094547139.USD","LU0345770993.USD","LU2237438978.USD","LU2237443382.USD","IE00B775H168.HKD","SG9999018865.SGD","LU0210536198.USD","SGXZ81514606.USD","SGXZ57979304.SGD","LU0289739699.SGD","LU2028103732.USD","LU2063271972.USD","LU1551013425.SGD","LU0058720904.USD","LU0114720955.EUR","LU0198837287.USD","LU1057294990.SGD","LU2361044949.HKD","LU2462157665.USD","LU2237443978.SGD","LU0320765992.SGD","LU2237443549.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2552382058.USD","FHLC","LU2108987350.USD","SGXZ31699556.SGD","LU1093756168.USD","ELIL","LU1868836757.USD","LU2023250330.USD","LU0882574139.USD","LU0943347566.SGD","LU2357305700.SGD","IE00BKDWB100.SGD","LU1720051017.SGD","VHT","LU1868836914.USD","IYH","BK4599","LU1712237335.SGD","LU0106261372.USD","LU2168564222.USD","LU2023251221.USD","LU0353189680.USD","LU2462591350.SGD","BK4211","SG9999014898.SGD","JDOC","LLY","LU0882574055.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU2112291526.USD","LU2211815571.USD","FTXH","LU0079474960.USD","LU2168564495.EUR","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU1267930730.SGD","LU0823434740.USD","GB00BDT5M118.USD","LU0471298777.SGD","LU1145028129.USD","LU0316494557.USD","LU2168564065.EUR","LU1629891620.HKD","LU2106854487.HKD","IE00BJJMRX11.SGD","HRTS","XLV","LU0096364046.USD","IE00B7KXQ091.USD","LU1093756325.SGD","LU1232071149.USD","LU2236285917.USD","LU0689472784.USD","IE00BJJMRY28.SGD","GDOC","LU0466842654.USD","SG9999018857.SGD","LU0820561818.USD","LU0823434583.USD","SGXZ99366536.SGD","LU0234572021.USD","OZEM","LU1127390331.HKD","LU0122379950.USD","IE00B1XK9C88.USD","BK4581","LU0174119429.USD","LU2756315318.SGD","LU2552382132.HKD","IE00BJLML261.HKD","LU1988902786.USD","LU0354030438.USD","LU0158827781.USD","LU2468319806.SGD","MEDX","SG9999013999.USD","SG9999015945.SGD","LU0203202063.USD","LU0432979614.USD","ILDR","LU0238689110.USD","IHE","LU1720051108.HKD","LU0471298694.HKD","LU2087625088.SGD","WDNA","LU1548497426.USD","LU0158827948.USD","LU1551013342.USD","IE00BK4W5L77.USD","SG9999001176.USD","BK4585","LU2264538146.SGD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","LLYZ","LU1691799644.USD","IE0002141913.USD","BK4534","LLYX","LU0786609619.USD","LU0889565916.HKD","LU1983299246.USD","LU0353189763.USD","CURE","LU0385154629.USD","LU0203201768.USD","THNR","LU1323610961.USD","LU1623119135.USD","IE0004445015.USD","LU0823416689.USD","SG9999014906.USD","LU1868837300.USD","BK4533","LU2360106947.USD","LU1035775433.USD","LU1064131342.USD","LU2896262040.SGD","LU2111349929.HKD","LU0354030511.USD","LU2089283258.USD","IE00B4R5TH58.HKD","PPH","LU0320765059.SGD","LU2417539215.USD","LU0708995401.HKD","LU2271345857.HKD","LU2602419157.SGD","SG9999015986.USD","SG9999015978.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","PJP","LU0683600562.USD","LU2750360997.AUD","TRUH","LU2265009873.SGD","LU0820561909.HKD","LU1023059063.AUD","BK4588","LU1061106388.HKD","SG9999014914.USD","LU2491050154.USD","LU1814569148.SGD","LU2089284900.SGD","LU2168564149.EUR","LU2237443465.HKD","BK4007","LU0820562030.AUD","LU0006306889.USD","LU1979441026.SGD","LU0109391861.USD","LU1989771016.USD","MEDI","LU2552382215.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0061475181.USD","LU2023250504.SGD","LU2471134796.USD","LU0133085943.USD","IE00B2B36J28.USD","SG9999015952.SGD","LU0640476718.USD","ASB","LU2491049909.HKD","ELIS","LU0787776722.HKD","LU1868837136.USD","SG9999001176.SGD","LU0417517546.SGD","LU2471134952.CNY","LU2491050071.SGD","TMED","LU0097036916.USD","LU2237443895.HKD","LU2213496289.HKD","IE00BN29S564.USD","LU0672654240.SGD","LU0964807845.USD","LU2237443622.USD","LU0256863902.USD","BK4516","LU0323591593.USD","LU0266013472.USD","LU1917777945.USD","LU2471134879.HKD","LU2746668461.USD","LU2089984988.USD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00BZ08YS42.EUR","IBB","BBH","IE0002141913.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU2242652126.USD","BK1515","IE00B2B36J28.USD","BIB","LU1057294990.SGD","LU1571399168.USD","PJP","01177","LU0109394709.USD","LU1983299246.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","SG9999001440.SGD","IBBQ","BK4533","BK4599","LU0289739699.SGD","BK1589","BK4588","LU2468319806.SGD","BK4566","LU0868494617.USD","LU0122379950.USD","BK1521","BK1191","AMGN","LU0320765992.SGD","LU0058720904.USD","IE0009355771.USD","TBXU","BK4534","IE00BZ08YR35.GBP","LU1061106388.HKD","IE00BJT1NW94.SGD","PBE","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0456855351.SGD","LU0058720904.USD","MEDX","BK4007","BK4550","LU0070302665.USD","IE00BBT3K403.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2596442595.SGD","BK4578","IE00B19Z3581.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4568","BK4533","BK4532","SG9999001176.SGD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","IE00BLSP4452.SGD","NVS","LU0211331839.USD","SG9999002224.SGD","BK4588","LU1057294990.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1894683348.USD","LU0225771236.USD","IE00B19Z3B42.SGD","BK4599","LU1066051498.USD","BK4592","LU0321505439.SGD","LU1883839398.USD","LU0985481810.HKD","SG9999013999.USD","LU0306807586.USD","BK4581","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0321505868.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU0170899867.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","OZEM","PFE","LU1023059063.AUD","PPH","BK4534","SG9999001176.USD","SG9999002232.USD","SG9999011175.SGD","IE00BJT1NW94.SGD","LU0208291251.USD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","LU2242646821.SGD","TBXU","BK4532","IBB","NVS","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","BK4007","IE0002141913.USD","AMGN","LU0211331839.USD","LU0889565916.HKD","IE0009355771.USD","PPH","LU0868494617.USD","LU0320765489.SGD","IBBQ","BK4566","LU0070302665.USD","LU1061106388.HKD","PBE","MEDX","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","OZEM","BK4599","BK4007","LU1093756325.SGD","LU1093756168.USD","NVO","NVOC","NVOX","BK7007","IE00BZ1G4Q59.USD","THNR","BK4532","LU0154236417.USD","PPH","BK4588","NVOH","CC5.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYF","LU2456880835.USD","LU2112291526.USD","BBH","LU0130102774.USD","LU0314106906.USD","LU2236285917.USD","PJP","TFNS","BK4007","BIB","LU0211331839.USD","LU1057294990.SGD","BK4504","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","PBE","PPH","LU0980610538.SGD","LU0320765489.SGD","LU0106831901.USD","LU1074936037.SGD","BK4566","BK4581","BK4533","LU1162221912.USD","BK4559","SG9999001440.SGD","TBXU","BK4139","IBBQ","IBB","LU0889565916.HKD","IE00BSNM7G36.USD","LU1061106388.HKD","MEDX","LU1244550221.USD","LU2125154935.USD","LU2462157665.USD","LU0868494617.USD","LU2360032135.SGD","LU0128525689.USD","BK4599","LU0070302665.USD","NVS","FTXO","LU2242652126.USD","LU0052756011.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665363786","title":"Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665363786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665363786?lang=en_us&edition=fundamental","pubTime":"2026-09-05 23:02","pubTimestamp":1788620534,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly reshaping its l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-ramps-up-obesity-and-eczema-bets-investors-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-ramps-up-obesity-and-eczema-bets-investors-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002232.USD","LU0058720904.USD","SG9999013999.USD","SG9999001176.USD","BK4588","LU1057294990.SGD","BK4534","IE00BBT3K403.USD","LU1883839398.USD","LU0234572021.USD","LU0985481810.HKD","LU1894683264.USD","LU0321505868.SGD","BK4568","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0456855351.SGD","IE00B19Z3581.USD","LU0225771236.USD","SG9999003800.SGD","LU0868494617.USD","BK4581","SG9999001176.SGD","IE00BLSP4239.USD","LU0122379950.USD","LU1066053197.SGD","LU0306807586.USD","LU2596442595.SGD","BK4533","BK4007","LU1066051498.USD","BK4585","LU0321505439.SGD","OZEM","BK4550","LU0306806265.USD","IE00B3T34201.USD","SG9999011175.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU0170899867.USD","LU1023059063.AUD","PFE","LU0225284248.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352504","title":"Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352504","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352504?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:53","pubTimestamp":1788562416,"startTime":"0","endTime":"0","summary":"Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statementAmgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing.Disclaimer:This new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6SPhM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","LU2242646821.SGD","TBXU","IBB","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE0002141913.USD","AMGN","LU0889565916.HKD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","IBBQ","BK4566","PBE","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665516603","title":"Pfizer Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665516603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665516603?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:36","pubTimestamp":1788554160,"startTime":"0","endTime":"0","summary":"DJ Pfizer Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Pfizer Inc.  shed 1.25% to $28.45 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.This was the stock's second consecutive day of losses.Pfizer Inc. closed 2.60% short of its 52-week high of $29.21, which the company achieved on September 3rd.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Eli Lilly & Co.  fell 0.88% to $1,149.36, and Abbott Laboratories  fell 0.42% to $108.33.Trading volume  remained 17.2 million below its 50-day average volume of 40.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0456855351.SGD","BK4534","IE00BBT3K403.USD","BK4588","BK4592","BK4007","LU0234572021.USD","LU1066053197.SGD","PFE","SGXZ57979304.SGD","BK4533","IE0002270589.USD","LU0321505439.SGD","BK4568","BK4599","LU0170899867.USD","SG9999003800.SGD","SG9999011175.SGD","SG9999001176.USD","SG9999001176.SGD","LU0225284248.USD","LU0868494617.USD","SG9999002224.SGD","SG9999013999.USD","SG9999002232.USD","IE00B19Z3B42.SGD","LU0321505868.SGD","LU1066051498.USD","BK4550","IE00BLSP4452.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","LU0985481810.HKD","LU1883839398.USD","LU0306806265.USD","LU0122379950.USD","LU0306807586.USD","OZEM","BK4581","IE00BLSP4239.USD","LU1057294990.SGD","IE000M9KFDE8.USD","LU0058720904.USD","LU1023059063.AUD","LU1894683264.USD","LU0289739699.SGD","LU2596442595.SGD","BK4585","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","LU0198837287.USD","LU1804176565.USD","MRNA","LU1323610961.USD","LU0289739699.SGD","SG9999013999.USD","LU0316494557.USD","LU0096364046.USD","LU2756315318.SGD","BK4501","IE00BJJMRY28.SGD","LU2023250330.USD","LU0109394709.USD","LU0158827948.USD","LU0210536198.USD","IE00BJT1NW94.SGD","LU0320765059.SGD","TRUH","LU2264538146.SGD","LLY","BK4007","LU2211815571.USD","LU1069344957.HKD","LU1868837136.USD","LU0256863902.USD","LU2087625088.SGD","LU2237443978.SGD","LU2552382215.SGD","BK4532","LU0058720904.USD","LU0345770308.USD","IHF","LLYX","LU0708995401.HKD","LU1551013425.SGD","LU2324357040.USD","LU2746668461.USD","LU0354030511.USD","LU2168564065.EUR","JDOC","LU0320765992.SGD","MEDI","IE00BFSS8Q28.SGD","LLII","LU0225283273.USD","LU2552382058.USD","MRNY","BK4533","LU0114720955.EUR","LU2168564222.USD","LU2746668974.SGD","WDNA","LU2265009873.SGD","LU0882574139.USD","LU2028103732.USD","SG9999014880.SGD","LU2089984988.USD","SG9999014898.SGD","SGXZ31699556.SGD","LU1868836914.USD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU2089284900.SGD","LGHT","IE00B775H168.HKD","LU1057294990.SGD","LU2471134879.HKD","SG9999015945.SGD","LU1720051108.HKD","LU0097036916.USD","SG9999001176.USD","LU1814569148.SGD","LU2106854487.HKD","BK4568","LU2360106947.USD","LU0158827781.USD","IDNA","ELIL","IE0005OL40V9.USD","LU0345770993.USD","LU0266013472.USD","OZEM","RXL","XBI","LU2896262040.SGD","BK4581","LU1232071149.USD","LU2089283258.USD","LU2468319806.SGD","LU2462157665.USD","LU0786609619.USD","LU0094547139.USD","LU1868837300.USD","LU2063271972.USD","LU0061475181.USD","LU0683600562.USD","LU0133085943.USD","ILDR","SG9999017495.SGD","IE00B1XK9C88.USD","LU0471298777.SGD","LU1267930730.SGD","LU0964807845.USD","LU2111349929.HKD","LU2237443622.USD","LU0385154629.USD","AGNG","IE00B7KXQ091.USD","LU2237438978.USD","LU2491049909.HKD","LU2168564495.EUR","LU2552382132.HKD","LU1093756168.USD","LU0471298694.HKD","LU1551013342.USD","LU1127390331.HKD","LU0456855351.SGD","SG9999001176.SGD","ELIS","LU2023250504.SGD","LU0174119429.USD","LU1979441026.SGD","LU2271345857.HKD","MHIP","LU0787776722.HKD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU2456880835.USD","LU1548497426.USD","LU0417517546.SGD","TMED","IE00BJLML261.HKD","LU2491050154.USD","LU0203201768.USD","IE00BN29S564.USD","LU0889565916.HKD","LU1064131342.USD","LU2471134523.USD","FHLC","IE0004445015.USD","LU2491050071.SGD","LU2236285917.USD","LU2756315664.SGD","LU0823434583.USD","MEDX","LU0820561909.HKD","LU1291159041.SGD","SGXZ57979304.SGD","IHE","LU1280957306.USD","LU2750360997.AUD","LU0106261372.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1145028129.USD","LU0823434740.USD","LU1974910355.USD","LU2471134952.CNY","LU0820561818.USD","LU1917777945.USD","BK4516","LU0820562030.AUD","LU1720051017.SGD","LU2417539215.USD","IBB","LU0353189680.USD","FTXH","IE0004445239.USD","LU0109391861.USD","PJP","GB00BDT5M118.USD","IE0002141913.USD","LU2168564149.EUR","LU1035775433.USD","LABU","LU1868836591.USD","LU0079474960.USD","LU1093756325.SGD","MRNX","SG9999015952.SGD","LU1629891620.HKD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2168563687.JPY","IE00B4JS1V06.HKD","LU0323591593.USD","LU1366192091.USD","SG9999018857.SGD","LU0238689110.USD","LU0823416689.USD","LU1061106388.HKD","LU0354030438.USD","LU2361045086.USD","LU2023251221.USD","LU1988902786.USD","LU0672654240.SGD","LU0882574055.USD","LU0353189763.USD","PPH","SGXZ51526630.SGD","XLV","SGXZ81514606.USD","LU0006306889.USD","LU2750360641.GBP","IE00BKDWB100.SGD","LU2357305700.SGD","LU0432979614.USD","LU0122379950.USD","LU0466842654.USD","LU0256863811.USD","LU2108987350.USD","BK4551","BK4588","LLYZ","LU0640476718.USD","BK4599","LU2461242641.AUD","BK4534","LU1868836757.USD","LU1023059063.AUD","GDOC","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","IE0001KFT4U8.USD","LU1691799644.USD","LU2602419157.SGD","BK4585","LU2237443465.HKD","SG9999018865.SGD","LU1983299246.USD","BK4139","IE00BK4W5L77.USD","SG9999014906.USD","LU2112291526.USD","LU0203202063.USD","THNR","LU0234572021.USD","LU2237443549.SGD","LU2361044865.SGD","LU1989771016.USD","LU2361044949.HKD","LU0943347566.SGD","GNOM","LU2213496289.HKD","LU2471134796.USD","SG9999014914.USD","IE0009355771.USD","HRTS","BK4548","IE00BWXC8680.SGD","LU2237443895.HKD","IE00B2B36J28.USD","SG9999015978.USD","IE00BJJMRX11.SGD","CANC","LU2462591350.SGD","LU1623119135.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665274353","title":"Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665274353","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665274353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:32","pubTimestamp":1788539536,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched VESPER-JM, a Phase 3 study in Japan that test...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-next-move-in-obesity-drugs-what-the-new-vesper-jm-trial-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-next-move-in-obesity-drugs-what-the-new-vesper-jm-trial-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","PFE","IE00B3T34201.USD","SGXZ57979304.SGD","BK4568","BK4599","LU1894683348.USD","IE00BLSP4239.USD","LU0234572021.USD","IE00B19Z3B42.SGD","BK4550","SG9999011175.SGD","BK4533","LU0122379950.USD","BK4007","LU0170899867.USD","LU0321505868.SGD","LU0868494617.USD","LU0289739699.SGD","SG9999001176.USD","BK4592","LU1057294990.SGD","LU0306806265.USD","SG9999002224.SGD","LU0225284248.USD","LU1066053197.SGD","BK4585","LU1066051498.USD","IE00BBT3K403.USD","LU1894683264.USD","IE00BLSP4452.SGD","OZEM","LU1883839398.USD","SG9999003800.SGD","SG9999013999.USD","BK4588","SG9999001176.SGD","LU0321505439.SGD","IE00B19Z3581.USD","LU0985481810.HKD","SG9999002232.USD","LU1023059063.AUD","LU0456855351.SGD","BK4534","LU0306807586.USD","IE0002270589.USD","BK4581","LU2596442595.SGD","IE000M9KFDE8.USD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353242","title":"Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353242","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353242?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539500,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a Phase 3 study in Japan called VESPER-JW to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizer-steps-up-in-obesity-race-with-new-phase-3-berobenatide-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizer-steps-up-in-obesity-race-with-new-phase-3-berobenatide-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU2596442595.SGD","LU0306807586.USD","LU0321505868.SGD","OZEM","SG9999011175.SGD","PFE","IE00B3T34201.USD","LU0306806265.USD","LU1066051498.USD","LU0321505439.SGD","LU0170899867.USD","LU0868494617.USD","LU0058720904.USD","SG9999001176.SGD","BK4592","BK4568","LU0234572021.USD","BK4585","LU1057294990.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","LU0985481810.HKD","BK4588","SGXZ57979304.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SG9999002224.SGD","BK4550","SG9999013999.USD","LU1883839398.USD","SG9999001176.USD","BK4007","IE00B19Z3B42.SGD","LU0225284248.USD","LU1066053197.SGD","LU1894683264.USD","BK4599","SG9999002232.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0225771236.USD","IE0002270589.USD","LU1894683348.USD","BK4581","SG9999003800.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665835320","title":"Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665835320","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665835320?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539471,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756325.SGD","NVOC","BK4007","NVOX","OZEM","PPH","NVOH","BK4588","IE00BKVL7J92.USD","THNR","NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4585","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665135376","title":"Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665135376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665135376?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539464,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is launching a new Phase 1 study on t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0820562030.AUD","MHIP","LU0266013472.USD","LU2461242641.AUD","RXL","ELIL","SG9999015978.USD","LU2089284900.SGD","LU2602419157.SGD","PPH","SG9999015986.USD","LU1323610961.USD","IE00BKPKM429.USD","LU1232071149.USD","LU0061475181.USD","LU1804176565.USD","LU0256863902.USD","LU2023251221.USD","LU2089283258.USD","LLYX","LU2361044949.HKD","SGXZ31699556.SGD","IYH","AGNG","LU0466842654.USD","SGXZ57979304.SGD","IXJ","LU2471134879.HKD","SG9999013999.USD","LU1720051017.SGD","LU0158827781.USD","LU0234572021.USD","LU1691799644.USD","LU0882574139.USD","LU2361045086.USD","OZEM","LU0943347566.SGD","LLII","LU2063271972.USD","IE00BFSS7M15.SGD","LU0354030511.USD","LU2237443978.SGD","LU0097036916.USD","SG9999001176.SGD","LU1145028129.USD","LU2028103732.USD","LU0058720904.USD","LU1551013342.USD","LU0096364046.USD","LU2750360641.GBP","LU2361044865.SGD","LU0238689110.USD","SGXZ51526630.SGD","LLYZ","LU0787776722.HKD","LU2237443549.SGD","LU0158827948.USD","SG9999014880.SGD","LU2746668974.SGD","MEDI","LU0006306889.USD","VHT","IE00B1XK9C88.USD","SG9999014906.USD","BK4581","LU0820561818.USD","LU2111349929.HKD","LU2360106947.USD","LU0456855351.SGD","LU2237443895.HKD","LLY","IE0002141913.USD","IE00BWXC8680.SGD","LU0786609619.USD","LU0109391861.USD","IE00B2B36J28.USD","LU1267930730.SGD","LU0672654240.SGD","LU1093756325.SGD","LU0708995401.HKD","LU2265009873.SGD","LU0345770308.USD","IE00B7KXQ091.USD","LU0353189680.USD","LU0889565916.HKD","LU0210536198.USD","SGXZ81514606.USD","LU0289739699.SGD","LU1974910355.USD","BK4599","LU2456880835.USD","TRUH","LU1366192091.USD","JDOC","LU2468319806.SGD","LU2896262040.SGD","LU0316494557.USD","IE0004445015.USD","LU0823434583.USD","LU1712237335.SGD","LU2087625088.SGD","LU2023250504.SGD","LU0683600562.USD","LU2264538146.SGD","LU0432979614.USD","GDOC","LU0320765059.SGD","LU0353189763.USD","LU1814569148.SGD","LU0225283273.USD","IE00BK4W5L77.USD","BK4534","SGXZ99366536.SGD","SG9999014898.SGD","LU2552382058.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU0882574055.USD","LU2750360997.AUD","THNR","LU2089984988.USD","IE0004445239.USD","IE00B775H168.HKD","IE00BFTCPJ56.SGD","IE00BJJMRY28.SGD","BK4585","LU1989771016.USD","LU2168564149.EUR","SG9999001176.USD","LU1979441026.SGD","CURE","LU1868837136.USD","LU0471298777.SGD","LU0114720955.EUR","LU2023250330.USD","LU2112291526.USD","LU2357305700.SGD","LU0820561909.HKD","LU1868836591.USD","LU2417539215.USD","LU1720051108.HKD","IHE","LU1127390331.HKD","SG9999017495.SGD","LU2168564495.EUR","LU1868837300.USD","LU1035775433.USD","LU2491049909.HKD","LU2491050154.USD","LU1057294990.SGD","LU0417517546.SGD","MEDX","LU2168564222.USD","LU0385154629.USD","LU1093756168.USD","LU2106854487.HKD","LU2271345857.HKD","LU1291159041.SGD","IE00BJJMRX11.SGD","LU1023059063.AUD","LU2237443622.USD","LU2237443465.HKD","BK4533","LU2324357040.USD","LU0823434740.USD","SG9999015945.SGD","BK4588","LU0106261372.USD","FTXH","LU0256863811.USD","LU1917777945.USD","LU2491050071.SGD","CANC","LU0122379950.USD","LU0471298694.HKD","LU0320765992.SGD","LU0689472784.USD","LU2471134523.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU0640476718.USD","FHLC","BK4007","IE00BN29S564.USD","LU1064131342.USD","IE00B4R5TH58.HKD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU0133085943.USD","LU0203201768.USD","LU0823416689.USD","LU2756315318.SGD","SG9999018857.SGD","LU0323591593.USD","TMED","XLV","LU0198837287.USD","LU1551013425.SGD","LU0964807845.USD","LU2552382215.SGD","IE00B4JS1V06.HKD","LU2211815571.USD","SG9999018865.SGD","LU2746668461.USD","LU0174119429.USD","LU1988902786.USD","LU0079474960.USD","LU1629891620.HKD","LU0094547139.USD","LU2168563687.JPY","LU2471134952.CNY","PJP","LU1868836914.USD","LU2236285917.USD","LU2756315664.SGD","LU2108987350.USD","LU0109394709.USD","LU1983299246.USD","LU0345770993.USD","IE00BK4W5M84.HKD","LU1069344957.HKD","LU1623119135.USD","LU2168564065.EUR","LU2237443382.USD","LU1548497426.USD","LU2462591350.SGD","ILDR","LU1868836757.USD","LU0354030438.USD","SG9999014914.USD","IE00BJLML261.HKD","BK4516","LU2462157665.USD","SG9999015952.SGD","GB00BDT5M118.USD","IE0009355771.USD","ELIS","IE00BKDWB100.SGD","LU1280957306.USD","IE00B1BXHZ80.USD","WDNA","LU2213496289.HKD","LU0203202063.USD","IE0001KFT4U8.USD","IE00BFSS8Q28.SGD","LU2552382132.HKD","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665222353","title":"Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665222353","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665222353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:30","pubTimestamp":1788539449,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 3 trial called “A randomized, double-bl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-tilrekimig-eczema-trial-a-fresh-phase-3-catalyst-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-tilrekimig-eczema-trial-a-fresh-phase-3-catalyst-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0321505439.SGD","IE00B3T34201.USD","LU0321505868.SGD","IE00B19Z3581.USD","LU0234572021.USD","SG9999011175.SGD","BK4588","SG9999001176.SGD","BK4534","LU1894683264.USD","LU0170899867.USD","SG9999003800.SGD","LU0868494617.USD","SGXZ57979304.SGD","BK4599","BK4585","LU1066053197.SGD","LU0306806265.USD","SG9999001176.USD","IE0002270589.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","LU0289739699.SGD","LU2596442595.SGD","BK4568","PFE","LU0306807586.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0225771236.USD","IE00BLSP4239.USD","LU0985481810.HKD","LU1023059063.AUD","LU0225284248.USD","LU0122379950.USD","LU0058720904.USD","BK4533","IE00B19Z3B42.SGD","LU1066051498.USD","LU1894683348.USD","OZEM","SG9999013999.USD","BK4592","BK4550","IE000M9KFDE8.USD","SG9999002224.SGD","LU1883839398.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935321","title":"Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935321?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:30","pubTimestamp":1788539437,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed a Phase 1 study called “A PHASE 1, OPEN LABE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-migraine-tablet-study-wraps-up-supporting-pipeline-flexibility-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-migraine-tablet-study-wraps-up-supporting-pipeline-flexibility-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","BK4007","IE000M9KFDE8.USD","LU1894683348.USD","LU1066051498.USD","BK4581","LU1894683264.USD","IE00B19Z3B42.SGD","LU1883839398.USD","LU0225284248.USD","BK4550","LU0289739699.SGD","IE00BLSP4452.SGD","LU0058720904.USD","BK4533","LU0306806265.USD","SG9999001176.SGD","IE00B19Z3581.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","BK4588","LU0321505868.SGD","BK4534","LU0170899867.USD","LU0868494617.USD","IE00B3T34201.USD","SG9999013999.USD","LU0225771236.USD","BK4592","LU0321505439.SGD","IE0002270589.USD","LU0306807586.USD","IE00BBT3K403.USD","LU0456855351.SGD","PFE","SG9999001176.USD","SGXZ57979304.SGD","LU1057294990.SGD","OZEM","SG9999002232.USD","BK4599","LU0985481810.HKD","SG9999011175.SGD","BK4568","LU0234572021.USD","LU1023059063.AUD","BK4585","IE00BLSP4239.USD","LU2596442595.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353356","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353356?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:02","pubTimestamp":1788537720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.9% to DKK298.90 Friday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,702.17.This was the stock's second consecutive day of losses.The company closed DKK111.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 3,129,002, compared to the 50-day average trading volume of 4,174,340.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","PPH","BK4532","LU0154236417.USD","LU1093756325.SGD","NVOC","NVOH","OZEM","NVO","THNR","NVOX","BK4585","BK4588","BK4599","IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}